Conexeu Sciences Inc. Common Stock

CNXU· NASDAQ· Health Care

$4.46+4.94%

2026-09-11

Valuation Metrics

Conexeu Sciences Inc. Common Stock's Market Cap is $119M. Ranked #3072 of 3,118 in US market (top 99%), #1419 of 1,460 on NASDAQ (top 97%) by Market Cap.

Investment Metrics(as of 2026-09-11)

Metric	Value	Rank
Size
Market Cap	$119M	US#3,072/3,118
Employees	4	US#2,807/3,118
Performance
1M Return	-38.99%	US#3,101/3,118
From 52W High	-73.59%	US#3,046/3,118
1Y MDD	-72.17%	US#2,986/3,118
Trading
Volume	114,120 shares	US#2,707/3,118
Trading Value	$505551.00	US#3,056/3,118

Company Info

CEO Miles Harrison

Employees 4

HQ Reno, US

Website www.conexeu.com

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.